---
title: GBM59 GBM Model - TD2 Precision Oncology
description: Explore GBM59 PDX for comprehensive brain cancer research - unlocking new insights.
image: https://td2inc.com/hubfs/Assets/GraphsFigures/gbm59.jpg
---
×
[](https://td2inc.com/?hsLang=en)
[](https://td2inc.com/?hsLang=en)
# GBM59 GBM Model
GBM59, a Patient-Derived Xenograft (PDX) model, is your ally in brain cancer research. Investigate its features to unlock new discoveries and advance the development of effective treatments. PDX models like GBM59 are invaluable for preclinical drug discovery because they faithfully mimic the patient’s tumor environment. GBM59 provides a platform to evaluate the efficacy and safety of drug candidates, streamlining the drug development process and offering promising solutions for brain cancer patients.
## Model Details
**Cancer Location:** Intracranial
**Cancer Type:** Brain Cancer
**Model Name:** GBM59
**Mouse Strain:** Nu/Nu
**Treatment Data Available:** Chemotherapy (Temozolomide), Radiation (2Gy)
**WES:** Yes
**RNAseq:** Yes
**Methylation:** Yes
**EGFR Exon Varient:** EGFRvIII
**PDX Treatment:** Yes
**Patient Treatment History:** Yes
## GBM59 Survival
Survival of orthotopic intracranial implanted GBM59 in Nu/Nu mice (n=10)
### Request Additional GBM Model Data
## CONTACT US
## Get Started.
Have questions about how TD2 can assist with your regulatory needs? Reach out to our expert staff today to get started.
[Get Started Now](https://td2inc.com/contact-us/?hsLang=en)
[](https://td2inc.com/?hsLang=en)
Office
13208 E. Shea Blvd,
Suite 100
Scottsdale, AZ 85259
Phone
(602) 358-8300
Connect with us
-
-
© 2026 Translational Drug Development. All Rights Reserved. [Terms and Conditions](https://td2inc.com/terms-and-conditions?hsLang=en) | [Privacy Policy](https://td2inc.com/privacy-policy?hsLang=en)